This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Reata brings in $17mm so far via its Series G round; adds $61mm
12 Jul 2010
Reata Pharmaceuticals (developing therapeutics for inflammation) has brought in $17mm so far through its Series G venture round from 30 investors. According to the company's Form D filing, it could bring in a total of $79.3mm. The second tranche of the money is linked to the success of Reata's Phase IIb trial of bardoxolone for diabetics with advanced chronic kidney disease.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?